Showing results (1-10 of 78) with videos related to
Sort By:
Pageof 8
Cancer Science|January 19, 2019
Roles of EphA1/A2 and ephrin-A1 in cancerKatsuaki Ieguchi, Yoshiro MaruAdvances in Experimental Medicine and Biology|October 30, 2020
Eph/Ephrin Signaling in the Tumor MicroenvironmentKatsuaki Ieguchi, Yoshiro MaruPlos One|March 5, 2015
Human serum amyloid A3 (SAA3) protein, expressed as a fusion protein with SAA2, binds the oxidized low density lipoprotein receptorTakeshi Tomita, Katsuaki Ieguchi, Tatsuya Sawamura, et al.Biochemical and Biophysical Research Communications|October 10, 2013
Ephrin-A1 expression induced by S100A8 is mediated by the toll-like receptor 4Katsuaki Ieguchi, Tsutomu Omori, Akiko Komatsu, et al.Journal of Visualized Experiments : Jove|March 19, 2019
Lung Tumor Cell Recruitment AssayTakeshi Tomita, Katsuaki Ieguchi, Atsuko Deguchi, et al.Oncotarget|September 1, 2018
Paradoxical counteraction by imatinib against cell death in myeloid progenitor 32D cells expressing p210BCR-ABLMorichika Takita, Fujiko Tsukahara, Taishi Mishima, et al.Journal of Biochemistry|August 31, 2018
C1D is not directly involved in the repair of UV-damaged DNA but protects cells from oxidative stress by regulating gene expressions in human cell linesTakeshi Tomita, Katsuaki Ieguchi, Morichika Takita, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|March 17, 2015
Eph as a target in inflammationKatsuaki IeguchiPlos One|October 1, 2014
ZFC3H1, a zinc finger protein, modulates IL-8 transcription by binding with celastramycin A, a potential immune suppressorTakeshi Tomita, Katsuaki Ieguchi, Frédéric Coin, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|May 26, 2015
Drug Targeting Based on a New Concept-Targeting Against TLR4 as an ExampleYoshiro Maru, Takeshi Tomita, Atsuko Deguchi, et al.Pageof 8